HANDL THERAPEUTICS
Handl Therapeutics is a developer of a therapeutics platform to deliver transformative advanced medicines to the market.
HANDL THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
Leuven, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.handltherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+32 (0)16 88 28 70
Total Funding:
3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apache Google Maps Apache 2.4 Ubuntu Adobe Dreamweaver OzServers
Similar Organizations
Carrick Therapeutics
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Flanders Innovation and Entrepreneurship (VLAIO)
Flanders Innovation and Entrepreneurship (VLAIO) investment in Grant - Handl Therapeutics
Official Site Inspections
http://www.handltherapeutics.com
- Host name: 162.13.217.138
- IP address: 162.13.217.138
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Handl Therapeutics"
Handl Therapeutics - Crunchbase Company Profile
Handl Therapeutics was acquired by Union Chimique Belge on Nov 12, 2020. Where is Handl Therapeutics's headquarters? Handl Therapeutics is located in Leuven, Vlaams-Brabant, Belgium. Who invested in Handl Therapeutics? …See details»
Handl Therapeutics Company Profile 2024: Valuation, …
Handl Therapeutics General Information Description. Operator of a gene therapy company intended to treat neurodegenerative diseases. The company's platform specializes in vivo gene therapy to treat complex neurodegenerative diseases, …See details»
Handl Therapeutics | VentureRadar
Handl Therapeutics deploys the power of disease modifying in vivo gene therapy to treat complex neurodegenerative diseases. KU Leuven. Associated sectors: Gene Therapy; Similar …See details»
Company Information - RocketReach
The vision of Handl Therapeutics is to deploy the power of disease modifying in vivo gene therapy to treat complex neurodegenerative diseases to start addressing significant unmet medical …See details»
Handl Therapeutics - VentureRadar
Handl Therapeutics deploys the power of disease modifying in vivo gene therapy to treat complex neurodegenerative diseases. KU Leuven Associated sectors: Gene Therapy;See details»
Handl Therapeutics - Overview, News & Similar companies
Who is Handl Therapeutics. The vision of Handl Therapeutics is to deploy the power of disease modifying in vivo gene therapy to treat complex neurodegenerative diseases to st art …See details»
Union Chimique Belge acquires Handl Therapeutics - Crunchbase
Nov 12, 2020 Acquired Organization: Handl Therapeutics Handl Therapeutics is a developer of a therapeutics platform to deliver transformative advanced medicines to the market. Acquiring …See details»
Handl Therapeutics - Contacts, Employees, Board Members
Organization. Handl Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Handl Therapeutics Company Profile: , Investments, Contact …
The vision of Handl Therapeutics is to deploy the power of disease modifying in vivo gene therapy to treat complex neurodegenerative diseases to start addressing significant unmet medical …See details»
UCB inks Handl buyout to boost nascent gene therapy …
Nov 12, 2020 UCB has struck a deal to buy gene therapy startup Handl Therapeutics. The takeover, which was disclosed alongside a separate gene therapy collaboration, positions UCB to accelerate its push into genetic …See details»
Handl Therapeutics B.V. - life-sciences-europe.com
BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry Association (BIA) …See details»
Handl Therapeutics - EU-Startups
Handl Therapeutics is a developer of a therapeutics platform to deliver transformative advanced medicines to the market.See details»
UCB completes the integration of Handl Therapeutics
Jul 11, 2021 Handl Therapeutics BV is a Leuven-based, Belgium born, transformative gene therapy company with a vision to deploy the power of disease modifying in vivo gene therapy …See details»
Handl Therapeutics - VentureRadar
Similar Companies: Neuragen Biotherapeutics China Private Founded in 2021, Neuragen is a Chinese biotech company that focuses on the development of novel gene therapy drugs.. EG …See details»
Handl Therapeutics. Entrepreneurship. Cima Universidad de Navarra.
Handl Therapeutics is an emerging biotechnology company specializing in the development of gene therapy to treat neurodegenerative diseases. This company is focused on the …See details»
UCB acquires Handl, partners with Lacerta to reinforce gene …
Nov 13, 2020 UCB SA acquired Handl Therapeutics and partnered with Lacerta Therapeutics Inc. to strengthen its gene therapy operations. Belgium's Handl and Alachua, Fla.-based …See details»
UCB strengthens its gene therapy activities with additional pipeline ...
BRUSSELS, Nov. 12, 2020 /PRNewswire/ -- UCB today announced the acquisition of Handl Therapeutics BV, a rapidly growing and transformative gene therapy company based in …See details»
UCB acquires KU Leuven spin-off Handl Therapeutics
Nov 12, 2020 UCB today announced the acquisition of KU Leuven spin-off Handl Therapeutics, a rapidly growing and transformative gene therapy company based in Leuven, Belgium.. UCB …See details»
UCB Acquires Belgian Gene Therapy Firm Handl
Nov 12, 2020 The Brussels-based company has leant on its local knowledge to snap up Leuven-headquartered biotech Handl and its proprietary AAV capsid technology platform.See details»
Handl Therapeutics awarded research grant - flanders.bio
Sep 15, 2020 Handl Therapeutics was founded in 2019 and is based at the Bio-Incubator in Leuven, Belgium. www.handltherapeutics.com. Contact us flanders.bio Technologiepark …See details»